Efficacy and Feasibility of Ectoin® Inhalation Solution in Inflammatory Obstruction and Ageing of the Lung

NCT01225965 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

COPD
Particulate Matter Induced Inflammation of the Lung

Interventions

DEVICE: Ectoin Inhalation Solution
DEVICE: Placebo

Sponsor

Bitop AG